Skye Bioscience
-
Skye Bioscience gets Australian HREC nod to begin first-in-human phase 1 study of SBI-100 ophthalmic emulsion
81 0Skye Bioscience, Inc., a pharmaceutical company developing a proprietary, synthetic…
Read more